Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
AIDS/HIV
24%
Anti-hepatitis C Virus
8%
Antiretroviral
10%
Antiretroviral Therapy
23%
Antiviral Drugs
8%
Breast
5%
CD4 Count
11%
CD40
10%
CD40 Expression
6%
CD40 Gene
5%
Chronic Hepatitis B
11%
Chronic Hepatitis C
28%
Chronic Hepatitis C Virus Infection
11%
CIITA
5%
Co-infected Patients
55%
Co-infection
10%
Confidence Interval
8%
Confocal Fluorescence Microscopy
5%
Didanosine
8%
Drug-induced Liver Injury
5%
Ductal Carcinoma in Situ
6%
End-stage Liver Disease
5%
Gene Expression
9%
Graft Fixation
5%
Heart Failure
7%
Heart Transplant
5%
Heart Transplant Recipients
8%
Hepatitis B
5%
Hepatitis B Surface Antigen (HBsAg)
6%
Hepatitis B Virus
20%
Hepatitis C
11%
Hepatitis C Coinfection
9%
Hepatitis C Treatment
7%
Hepatitis C Virus
59%
Hepatitis C Virus Genotypes
18%
Hepatitis C Virus Infection
5%
Hepatitis C Virus RNA
15%
Hepatitis C Virus Therapy
10%
Hepatotoxicity
9%
HHV-8
5%
Highly Active Antiretroviral Therapy (HAART)
31%
HIV Infection
8%
HIV Patients
59%
HIV Viral Load
5%
HIV-HCV
7%
Infected Patients
16%
Interferon-α (IFN-α)
10%
Kaposi Sarcoma
5%
Knee
8%
Lamivudine
7%
Liver Disease
6%
Liver Fibrosis
7%
Liver Toxicity
14%
Lopinavir
5%
Macrophages
11%
Malignancy
5%
Microglia
16%
Nevirapine
8%
Odds Ratio
9%
Pegylated Interferon
5%
Pegylated Interferon Plus Ribavirin
11%
Pegylated Liposomal Doxorubicin
5%
Plasma Parameters
6%
Positron Emission Tomography-computed Tomography (PET-CT)
5%
Protease Inhibitors
6%
Resistance mutations
6%
Ribavirin
18%
Risk Factors
8%
Serum Hepatitis
5%
Sustained Virological Response
17%
Tenofovir
9%
Total Joint Arthroplasty
5%
Tumor
5%
Viremia
5%
Virological Failure
5%
Virus
7%
Pharmacology, Toxicology and Pharmaceutical Science
Aminotransferase
7%
Chronic Hepatitis B
12%
Chronic Hepatitis C
28%
Didanosine
7%
Doxorubicin
5%
Hepatitis B
9%
Hepatitis B Virus
24%
Hepatitis C
17%
Hepatitis C Virus
52%
Hepatitis C Virus Genotype 1
8%
Hepatitis C Virus Genotype 2
5%
Hepatitis C Virus Genotype 3
6%
Hepatotoxicity
18%
HIV
100%
Human Immunodeficiency Virus Infection
6%
Infection
9%
Interferon
9%
Kaposi Sarcoma
5%
Lamivudine
6%
Liver Fibrosis
7%
Liver Injury
5%
Lopinavir
5%
Mixed Infection
12%
Nevirapine
7%
Peginterferon
12%
Proteinase Inhibitor
8%
Ribavirin
21%
Tenofovir
8%
Toxic Hepatitis
5%
Virotherapy
7%
Virus Hepatitis
8%
Virus RNA
12%
Medicine and Dentistry
Anterior Cruciate Ligament
6%
Antiretroviral Therapy
7%
Arthroplasty
6%
Breast Cancer
9%
Cancer
6%
Chronic Hepatitis C
13%
Congestive Heart Failure
11%
Diseases
7%
Doxorubicin
5%
Fluorescence Microscopy
5%
Heart Graft
7%
Hepatitis B
5%
Hepatitis B Virus
11%
Hepatitis C
9%
Hepatitis C Virus
27%
Highly Active Antiretroviral Therapy
11%
Human immunodeficiency virus
58%
Human Immunodeficiency Virus Infection
6%
Interferon
5%
Intraductal Carcinoma
8%
Kaposi Sarcoma
5%
Left Ventricular Assist Device
6%
Mixed Infection
9%
Neoplasm
7%
Odds Ratio
7%
Peginterferon
5%
Proteinase Inhibitor
5%
Ribavirin
9%
Suture
6%
Systematic Review
10%
Tumor
6%
Virus RNA
5%